News: Breast Cancer

Next Page »

Gene linked to breast cancer therapy response

Friday, November 21st, 2014

A group of Vanderbilt-led investigators has identified a new gene mutation that may explain why some breast cancer patients do not respond to anti-hormone therapy. The study was published online in the Journal of Clinical Investigation. Luis Schwarz, M.D., and Emily Fox, Ph.D., served as co-first authors of the study, led by senior author Carlos […]

More breast cancer patients choose mastectomy

Friday, November 21st, 2014

Far more breast cancer patients are choosing to undergo mastectomy, including removal of both breasts, instead of choosing breast conservation surgery even when they have early stage disease that is confined to one breast, a Vanderbilt study shows.

New Insights on Postpartum Breast Cancer

Friday, October 31st, 2014

A new study explaining the cellular activity that leads to breast tumor metastasis among women who have recently given birth may offer new treatment direction for postpartum breast cancer.

VICC Investigators Earn Breast Cancer Grants

Thursday, October 23rd, 2014

Three Vanderbilt-Ingram Cancer Center (VICC) investigators have been awarded breast cancer research grants totaling $830,000 from the Susan G. Komen organization.

Study Seeks to Improve Lymphedema Care

Thursday, October 16th, 2014

A new Vanderbilt University School of Nursing (VUSN) study may lead to earlier detection and better outcomes for the 20-30 percent of breast cancer patients with lymphedema, the painful and stigmatizing arm swelling that often results from treatment.

Limiting Breast Cancer Metastasis

Thursday, August 28th, 2014

Targeting a cytokine pathway may offer a way to inhibit breast cancer cell survival and metastasis, study suggests.

New target for breast cancer therapy

Monday, August 4th, 2014

by Leigh MacMillan The protein MTBP is important for growth and survival of triple negative breast cancer (TNBC) – a clinically aggressive subtype of breast cancer that is commonly resistant to targeted therapeutics – Vanderbilt investigators have discovered. Using data from The Cancer Genome Atlas, Christine Eischen, Ph.D., MSTP student Brian Grieb, Ph.D., and colleagues […]

Komen breast cancer research grants

Friday, August 1st, 2014

by Dagny Stuart Two Vanderbilt-Ingram Cancer Center investigators have received multi-year breast cancer research grants from the Susan G. Komen for the Cure Breast Cancer Foundation. Justin Balko, Ph.D., Pharm.D., research assistant professor of Medicine, won support for his research project which will use molecular profiling to prioritize adjuvant targeted therapy for triple negative breast […]

Study on breast cancer in East Asian women

Tuesday, July 29th, 2014

by Dagny Stuart A new study in East Asian women has identified three genetic changes linked to an increased risk of breast cancer. The research, led by Vanderbilt University investigators, was published online this week in Nature Genetics. While breast cancer is one of the most common malignancies among women worldwide, most studies of the […]

Abramson lands breast cancer research award

Wednesday, July 23rd, 2014

by Dagny Stuart     Vandana Abramson, M.D., assistant professor of Medicine and a breast cancer specialist at Vanderbilt-Ingram Cancer Center, has received the Advanced Clinical Research Award in Breast Cancer from the Conquer Cancer Foundation (CCF). The CCF grants and awards support cancer research done by physician-scientists at every stage of their careers. Abramson’s […]